Position in MRK
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$1,149,047
+$42,139 QoQ
Shares Held
8,942
-2.8% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.69%
of 13F equity value
Holder Rank
#2,008
of 3,778 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Verity Asset Management, Inc. holds $13,024,966 across 11 Drug Manufacturers - General names. MRK ranks #6 (8.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AMGN |
Amgen Inc
|
8,729 | $3,160,945 | |
| 2 | BMY |
Bristol Myers Squibb Co
|
31,404 | $1,809,498 | |
| 3 | JNJ |
Johnson & Johnson
|
5,968 | $1,515,692 | |
| 4 | GSK |
GSK plc
|
25,025 | $1,311,810 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
10,134 | $1,280,329 | |
| 6 | MRK |
Merck & Co., Inc.
This page
|
8,942 | $1,149,047 | |
| 7 | LLY |
ELI LILLY & Co
|
569 | $682,475 | |
| 8 | ABBV |
AbbVie Inc.
|
2,707 | $681,189 |
All Filings in MRK
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,149,047 | 8,942 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $1,106,908 | 9,202 | Shares | Sole | 2026-04-21 | |
| 2025-12-31 | $918,498 | 8,726 | Shares | Sole | 2026-01-30 | |
| 2025-09-30 | $716,678 | 8,539 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $663,360 | 8,380 | Shares | Sole | 2025-08-05 | |
| 2025-03-31 | $753,894 | 8,399 | Shares | Sole | 2025-04-25 | |
| 2024-12-31 | $872,837 | 8,774 | Shares | Sole | 2025-01-27 | |
| 2024-09-30 | $936,642 | 8,248 | Shares | Sole | 2024-10-31 | |
| 2024-06-30 | $945,460 | 7,637 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $1,007,438 | 7,635 | Shares | Sole | 2024-05-28 | |
| 2023-12-31 | $832,149 | 7,633 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $789,420 | 7,668 | Shares | Sole | 2023-11-22 | |
| 2023-06-30 | $909,619 | 7,883 | Shares | Sole | 2023-08-16 | |
| 2023-03-31 | $836,012 | 7,858 | Shares | Sole | 2023-05-24 | |
| 2022-12-31 | $831,792 | 7,497 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $829,852 | 9,636 | Shares | Sole | 2022-11-16 | |
| 2022-03-31 | $774,059 | 9,434 | Shares | Sole | 2022-05-23 | |
| 2021-12-31 | $595,339 | 7,768 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $570,009 | 7,589 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $645,257 | 8,297 | Shares | Sole | 2021-08-04 | |
| 2021-03-31 | $573,164 | 7,435 | Shares | Sole | 2021-05-10 | |
| 2020-12-31 | $536,771 | 6,562 | Shares | Sole | 2021-02-05 | |
| 2020-09-30 | $462,197 | 5,572 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $398,327 | 5,151 | Shares | Sole | 2020-11-13 | |
| 2020-03-31 | $325,763 | 4,234 | Shares | Sole | 2020-05-18 | |
| No filing history on record for this holder in this stock. | ||||||